ARCHIVES

Managed Care Plans Seek Cost Efficacy, Not Research, Center Directors Warned

This article is from The Cancer Letter archive.

Vol. 21 No. 11 | March 17, 1995

Download PDF Visit The Full Archive

Related Articles

Study Links Ovarian Cancer To Hormone Replacement

May 25, 2007

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

January 27, 2006

In Brief: AACR, ASCO to Sponsor Joint Symposium on Oncogenes; AACI Hosts Congressional Staff

February 15, 1985

“Landmark” Fundings Reported n Interferon Genes, Ovarian And Pancreas Markers

April 17, 1981

Onward to 2010? NCI promises faster progress for more money.

May 20, 2005

FDA Approves Votrient For Renal Cell Carcinoma

October 23, 2009